Literature DB >> 9436875

Clinicomicrobiological review of Nocardia keratitis.

M S Sridhar1, S Sharma, M K Reddy, P Mruthyunjay, G N Rao.   

Abstract

PURPOSE: To present the clinical profile, laboratory results, and outcome of treatment in 16 patients with Nocardia keratitis.
METHODS: A retrospective review of 16 culture-proven cases of Nocardia keratitis was done. Clinical and microbiologic data were analyzed.
RESULTS: Nocardia constituted 1.7% of laboratory-confirmed bacterial keratitis and was seen predominantly in male subjects (13 of 16) with a mean age of 39.1 years. Although the predisposing factor was unknown in the majority, a definite history of trauma was present in four (25%) cases. Patchy stromal infiltrates were seen in 12 patients. Wreath pattern of infiltrates (six of 16) and hypopyon (nine of 16) were notable features. Nocardia was detectable in corneal scrapings of 10 patients with Gram stain and all patients with 1% acid-fast preparation (six of six). Nocardia asteroides was the causative agent in all except one (N. caviae). All isolates were sensitive to gentamicin; however, topical 30% sulfacetamide was the preferred drug for treatment. Favorable outcome (healed scar) was achieved in 11.
CONCLUSION: Although Nocardia keratitis is a rare condition, a high index of clinical suspicion should be kept in agricultural workers or in patients with trauma who have patchy stromal infiltrates. Sulfonamides are the initial drug of choice, and gentamicin could be an effective alternative. If recognized early, Nocardia keratitis responds to medical treatment with good visual recovery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9436875     DOI: 10.1097/00003226-199801000-00003

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

1.  Diagnosis and management of Nocardia keratitis.

Authors:  S Sharma; M S Sridhar
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Endogenous Nocardia farcinica endophthalmitis.

Authors:  Hideaki Kawakami; Akira Sawada; Kiyofumi Mochizuki; Ken Takahashi; Toshihiro Muto; Kiyofumi Ohkusu
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

3.  Nocardia transvalensis keratitis: an emerging pathology among travelers returning from Asia.

Authors:  Elodie Trichet; Stéphan Cohen-Bacrie; John Conrath; Michel Drancourt; Louis Hoffart
Journal:  BMC Infect Dis       Date:  2011-10-31       Impact factor: 3.090

4.  Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.

Authors:  Jeena Mascarenhas; Muthiah Srinivasan; Michael Chen; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; Catherine E Oldenburg; Kathryn J Ray; David V Glidden; Stephanie Costanza; Thomas M Lietman; Nisha R Acharya
Journal:  Int Ophthalmol       Date:  2012-06-30       Impact factor: 2.031

5.  Bilateral nocardia keratitis after photorefractive keratectomy.

Authors:  Amir Faramarzi; Sepehr Feizi; Mohammad-Ali Javadi; Mozhgan Rezaei Kanavi; Forouzan Yazdizadeh; Hamid-Reza Moein
Journal:  J Ophthalmic Vis Res       Date:  2012-04

6.  Nocardia keratitis mimicking superior limbic keratoconjunctivitis and herpes simplex virus.

Authors:  Eileen L Chang; Rachel L Chu; John R Wittpenn; Henry D Perry
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-13

Review 7.  Current diagnostic tools and management modalities of Nocardia keratitis.

Authors:  Mohammad Soleimani; Ahmad Masoumi; Sadegh Khodavaisy; Mostafa Heidari; Ali A Haydar; Alireza Izadi
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-12-02

8.  A case of amniotic membrane transplantation in non-healing Nocardia asteroides keratitis.

Authors:  Firoozeh Rahimi; Masood Aghsaie Fard; Reza Soltani Mogaddam
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-10

9.  Distinguishing infective versus noninfective keratitis.

Authors:  M Srinivasan; Jeena Mascarenhas; C N Prashanth
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.